INDEXES AND BOUNDARIES FOR QUANTITATIVE SIGNIFICANCE IN STATISTICAL DECISIONS

被引:191
作者
BURNAND, B
KERNAN, WN
FEINSTEIN, AR
机构
[1] YALE UNIV,SCH MED,DEPT MED,333 CEDAR ST,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT EPIDEMIOL,CLIN EPIDEMIOL UNIT,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,ROBERT WOOD JOHNSON CLIN SCHOLARS PROGRAM,NEW HAVEN,CT 06510
[4] VET ADM MED CTR,CTR COOPERAT STUDIES PROGRAM COORDINATING,W HAVEN,CT 06516
关键词
STATISTICAL SIGNIFICANCE; QUANTITATIVE SIGNIFICANCE; CLINICAL IMPORTANCE; STOCHASTIC SIGNIFICANCE; STATISTICAL DECISIONS;
D O I
10.1016/0895-4356(90)90093-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Boundaries for delta, representing a "quantitatively significant" or "substantively impressive" distinction, have not been established, analogous to the boundary of alpha, usually set at 0.05, for the stochastic or probabilistic component of "statistical significance". To determine what boundaries are being used for the "quantitative" decisions, we reviewed pertinent articles in three general medical journals. For each contrast of two means, contrast of two rates, or correlation coefficient, we noted the investigators' decisions about stochastic significance, stated in P values or confidence intervals, and about quantitative significance, indicated by interpretive comments. The boundaries between impressive and unimpressive distinctions were best formed by a ratio of greater-than-or-equal-to-1.2 for the smaller to the larger mean in 546 comparisons, by a standardized increment of greater-than-or-equal-to-0.28 and odds ratio of greater-than-or-equal-to-2.2 in 392 comparisons of two rates; and by an r value of greater-than-or-equal-to-0.32 in 154 correlation coefficients. Additional boundaries were also identified for "substantially" and "highly" significant quantitative distinctions. Although the proposed boundaries should be kept flexible, indexes and boundaries for decisions about "quantitative significance" are particularly useful when a value of delta must be chosen for calculating sample size before the research is done, and when the "statistical significance" of completed research is appraised for its quantitative as well as stochastic components.
引用
收藏
页码:1273 / 1284
页数:12
相关论文
共 27 条
[1]   GUIDELINES FOR STATISTICAL REPORTING IN ARTICLES FOR MEDICAL JOURNALS - AMPLIFICATIONS AND EXPLANATIONS [J].
BAILAR, JC ;
MOSTELLER, F .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :266-273
[2]   P VALUES VERSUS MEANS AND STANDARD ERRORS IN REPORTING DATA [J].
BOEN, JR .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (03) :535-&
[3]  
BREWER JK, 1975, AM STAT, V29, P171
[4]   STATISTICAL SIGNIFICANCE TESTS [J].
COX, DR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :325-331
[5]   ESTABLISHING THERAPEUTIC EQUIVALENCY - WHAT IS A CLINICALLY SIGNIFICANT DIFFERENCE [J].
DETSKY, AS ;
SACKETT, DL .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (05) :861-862
[6]   PUBLICATION BIAS AND CLINICAL-TRIALS [J].
DICKERSIN, K ;
CHAN, S ;
CHALMERS, TC ;
SACKS, HS ;
SMITH, H .
CONTROLLED CLINICAL TRIALS, 1987, 8 (04) :343-353
[7]   DEFINITION OF RATES - SOME REMARKS ON THEIR USE AND MISUSE [J].
ELANDTJOHNSON, RC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1975, 102 (04) :267-271
[8]  
Feinstein A.R., 1985, CLIN EPIDEMIOLOGY
[9]   CLINICAL BIOSTATISTICS .51. QUANTITATIVE SIGNIFICANCE AND STATISTICAL INDEXES FOR A CONTRAST OF 2 GROUPS [J].
FEINSTEIN, AR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :567-578
[10]  
FEINSTEIN AR, 1975, CLIN PHARMACOL THER, V18, P491